SUD
Click for more information
0.00% 4.2¢ suda pharmaceuticals ltd

In a report released today, Carl Byrnes from Northland...

  1. abitlikeme
    5,698 Posts.
    lightbulb Created with Sketch. 82
    clock Created with Sketch.
    20/03/19
    07:48
    Post #: 37817998
    In a report released today, Carl Byrnes from Northland Securities maintained a Buy rating on Aytu BioScience Inc (AYTU), with a price target of $10. The company’s shares opened today at $2.06.

    $10 would give them a MC of around $A200m.

    Wonder what Carl thinks of Suda.
    SUD Price at posting: 0.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 
watchlist Created with Sketch. Add SUD (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.